H. K. Hochkeppel

966 total citations
29 papers, 828 citations indexed

About

H. K. Hochkeppel is a scholar working on Immunology, Radiology, Nuclear Medicine and Imaging and Molecular Biology. According to data from OpenAlex, H. K. Hochkeppel has authored 29 papers receiving a total of 828 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Immunology, 10 papers in Radiology, Nuclear Medicine and Imaging and 9 papers in Molecular Biology. Recurrent topics in H. K. Hochkeppel's work include Monoclonal and Polyclonal Antibodies Research (10 papers), Immune Cell Function and Interaction (5 papers) and interferon and immune responses (4 papers). H. K. Hochkeppel is often cited by papers focused on Monoclonal and Polyclonal Antibodies Research (10 papers), Immune Cell Function and Interaction (5 papers) and interferon and immune responses (4 papers). H. K. Hochkeppel collaborates with scholars based in Switzerland, Germany and United States. H. K. Hochkeppel's co-authors include Michel A. Horisberger, A Boutonnier, D Jakschies, Ara G. Hovanessian, Axel Roers, Otto Haller, Dietmar G. Braun, Marc De Ley, Peter von Wussow and Joëlle Fournier and has published in prestigious journals such as Nature, Nucleic Acids Research and Journal of Biological Chemistry.

In The Last Decade

H. K. Hochkeppel

29 papers receiving 777 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. K. Hochkeppel Switzerland 16 345 269 251 190 118 29 828
N. B. Finter United Kingdom 19 406 1.2× 218 0.8× 171 0.7× 371 2.0× 170 1.4× 46 1.1k
Martine Y. K. Armstrong United States 17 430 1.2× 200 0.7× 349 1.4× 565 3.0× 175 1.5× 27 1.2k
Hana Schmeisser United States 14 384 1.1× 318 1.2× 154 0.6× 184 1.0× 161 1.4× 24 822
I. Gresser France 12 372 1.1× 112 0.4× 137 0.5× 116 0.6× 153 1.3× 14 634
Elizabeth Jones United Kingdom 17 624 1.8× 370 1.4× 266 1.1× 94 0.5× 94 0.8× 34 1.3k
Clare Thompson United States 9 680 2.0× 157 0.6× 98 0.4× 153 0.8× 119 1.0× 12 836
Gerald Eder Austria 15 143 0.4× 249 0.9× 251 1.0× 683 3.6× 62 0.5× 39 1.4k
R. Nayak India 18 241 0.7× 533 2.0× 256 1.0× 312 1.6× 235 2.0× 58 1.0k
William R. Addison Canada 14 203 0.6× 379 1.4× 142 0.6× 626 3.3× 62 0.5× 24 1.3k
Agnes E. Hamburger United States 13 262 0.8× 287 1.1× 108 0.4× 115 0.6× 156 1.3× 19 769

Countries citing papers authored by H. K. Hochkeppel

Since Specialization
Citations

This map shows the geographic impact of H. K. Hochkeppel's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. K. Hochkeppel with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. K. Hochkeppel more than expected).

Fields of papers citing papers by H. K. Hochkeppel

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. K. Hochkeppel. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. K. Hochkeppel. The network helps show where H. K. Hochkeppel may publish in the future.

Co-authorship network of co-authors of H. K. Hochkeppel

This figure shows the co-authorship network connecting the top 25 collaborators of H. K. Hochkeppel. A scholar is included among the top collaborators of H. K. Hochkeppel based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. K. Hochkeppel. H. K. Hochkeppel is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Schellekens, Huub, et al.. (1996). The effect of recombinant human interferon α BD compared to interferon α 2b on SIV infection in rhesus macaques. Antiviral Research. 32(1). 1–8. 4 indexed citations
2.
Roers, Axel, H. K. Hochkeppel, Michel A. Horisberger, Ara G. Hovanessian, & Otto Haller. (1994). MxA Gene Expression after Live Virus Vaccination: A Sensitive Marker for Endogenous Type I Interferon. The Journal of Infectious Diseases. 169(4). 807–813. 110 indexed citations
3.
Ghaffar, Abdul, et al.. (1992). Cross‐Species Antiviral Activity of a Recombinant Human Alpha‐Interferon Hybrida. Annals of the New York Academy of Sciences. 653(1). 314–322. 6 indexed citations
4.
Wussow, Peter von, D Jakschies, M. Freund, et al.. (1991). Treatment of anti‐recombinant interferon‐alpha 2 antibody positive CML patients with natural interferon‐alpha. British Journal of Haematology. 78(2). 210–216. 38 indexed citations
5.
Wussow, Peter von, D Jakschies, I. Schedel, et al.. (1990). The interferon-induced Mx-homologous protein in people with symptomatic HIV-1 infection. AIDS. 4(2). 119–124. 33 indexed citations
6.
Gangemi, J. David, Robert Cozens, Erik De Clercq, Jan Balzarini, & H. K. Hochkeppel. (1989). 9-(2-Phosphonylmethoxyethyl)adenine in the treatment of murine acquired immunodeficiency disease and opportunistic herpes simplex virus infections. Antimicrobial Agents and Chemotherapy. 33(11). 1864–1868. 66 indexed citations
7.
Hochkeppel, H. K.. (1989). Introduction. Cellular and Molecular Life Sciences. 45(6). 500–500. 1 indexed citations
8.
Jurado, A., et al.. (1989). The immunomodulatory effects of interferon-gamma on mature B-lymphocyte responses. Cellular and Molecular Life Sciences. 45(6). 521–526. 29 indexed citations
9.
Stoner, G. L., Caroline F. Ryschkewitsch, Duard L. Walker, et al.. (1988). Early Viral Proteins As Autoantigens. Annals of the New York Academy of Sciences. 540(1). 665–668. 2 indexed citations
10.
Horisberger, Michel A. & H. K. Hochkeppel. (1987). IFN-αInduced Human 78 kD Protein: Purification and Homologies with the Mouse Mx Protein, Production of Monoclonal Antibodies, and Potentiation Effect of IFN-γ. Journal of Interferon Research. 7(4). 331–343. 65 indexed citations
11.
Meyer, Thomas, et al.. (1986). Antagonism of Interferon Induction in Spleen and Adherent Peritoneal Cells of Mice by the Lipophilic Antiviral Muramyl Peptide MTP-PE. Journal of Interferon Research. 6(3). 183–188. 5 indexed citations
12.
Brandner, Gerhard, et al.. (1986). Transformation-Related Cellular Protein p53: Increased Level in Untransformed Rat Cells Following Treatment with the Tumorpromoter, Tetradecanoylphorbol-Acetate. Zeitschrift für Naturforschung C. 41(1-2). 94–99. 7 indexed citations
14.
Horisberger, Michel A. & H. K. Hochkeppel. (1985). An interferon-induced mouse protein involved in the mechanism of resistance to influenza viruses. Its purification to homogeneity and characterization by polyclonal antibodies.. Journal of Biological Chemistry. 260(3). 1730–1733. 19 indexed citations
15.
Hochkeppel, H. K., et al.. (1985). Biological activities of human recombinant interferon α/β targeted by anti‐Epstein‐Barr virus monoclonal antibodies. FEBS Letters. 179(1). 29–33. 5 indexed citations
16.
Alkan, Ş. Ş., et al.. (1984). Antiviral and Antiproliferative Effects of Interferons Delivered via Monoclonal Antibodies. Journal of Interferon Research. 4(3). 355–363. 12 indexed citations
17.
Bode, Juergen, H. K. Hochkeppel, & Karin Maass. (1982). Links Between Effects of Butyrate on Histone Hyperacetylation and Regulation of Interferon Synthesis in Namalva and FS-4 Cell Lines. Journal of Interferon Research. 2(2). 159–166. 7 indexed citations
18.
Hochkeppel, H. K. & Marc De Ley. (1982). Monoclonal antibody against human IFN-γ. Nature. 296(5854). 258–259. 37 indexed citations
19.
Müller, R., H. K. Hochkeppel, & H Klein. (1981). Demonstration of HIFN‐β in the liver of patients undergoing HIFN‐β treatment. FEBS Letters. 133(2). 194–196. 1 indexed citations
20.
Hochkeppel, H. K. & Julian Gordon. (1979). Evidence for crosslinking of polyribonucleotides with 4'-aminomethyl-4,5',8-trimethylpsoralen hydrochloride. Biochemistry. 18(13). 2905–2910. 7 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026